Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Updates on treatment of attention-deficit/hyperactivity disorder: facts, comments, and ethical considerations.

Rothenberger A, Rothenberger LG.

Curr Treat Options Neurol. 2012 Dec;14(6):594-607. doi: 10.1007/s11940-012-0197-2.

2.

Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.

Benkert D, Krause KH, Wasem J, Aidelsburger P.

GMS Health Technol Assess. 2010 Sep 7;6:Doc13. doi: 10.3205/hta000091.

3.

Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).

[No authors listed]

NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. Review.

PMID:
10868163
4.
5.
7.

[Attention deficit hyperactivity disorder].

Cunill R, Castells X.

Med Clin (Barc). 2015 Apr 20;144(8):370-5. doi: 10.1016/j.medcli.2014.02.025. Epub 2014 Apr 29. Review. Spanish.

PMID:
24787685
8.

Pharmacological and psychosocial treatments for adolescents with ADHD: an updated systematic review of the literature.

Sibley MH, Kuriyan AB, Evans SW, Waxmonsky JG, Smith BH.

Clin Psychol Rev. 2014 Apr;34(3):218-32. doi: 10.1016/j.cpr.2014.02.001. Epub 2014 Feb 27. Review.

PMID:
24632046
9.

Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis.

Arns M, de Ridder S, Strehl U, Breteler M, Coenen A.

Clin EEG Neurosci. 2009 Jul;40(3):180-9.

PMID:
19715181
10.

Evidence-based information on the clinical use of neurofeedback for ADHD.

Moriyama TS, Polanczyk G, Caye A, Banaschewski T, Brandeis D, Rohde LA.

Neurotherapeutics. 2012 Jul;9(3):588-98. doi: 10.1007/s13311-012-0136-7. Review.

11.

Treatment of attention-deficit/hyperactivity disorder.

Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R.

Evid Rep Technol Assess (Summ). 1999 Nov;(11):i-viii, 1-341.

12.

Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations.

Young S, Sedgwick O.

Expert Rev Neurother. 2015;15(9):1005-14. doi: 10.1586/14737175.2015.1059756. Epub 2015 Jul 30.

PMID:
26289485
13.
14.

Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder.

Pelham WE Jr, Fabiano GA.

J Clin Child Adolesc Psychol. 2008 Jan;37(1):184-214. doi: 10.1080/15374410701818681. Review.

PMID:
18444058
15.

Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Storebø OJ, Skoog M, Damm D, Thomsen PH, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008223. doi: 10.1002/14651858.CD008223.pub2. Review.

PMID:
22161422
16.

Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.

Chan E, Fogler JM, Hammerness PG.

JAMA. 2016 May 10;315(18):1997-2008. doi: 10.1001/jama.2016.5453. Review.

PMID:
27163988
17.
18.
19.

Pearls, perils, and pitfalls in the assessment and treatment of attention-deficit/hyperactivity disorder in adolescents.

Obioha O, Adesman A.

Curr Opin Pediatr. 2014 Feb;26(1):119-29. doi: 10.1097/MOP.0000000000000053. Review.

PMID:
24370490
20.

Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Martinez-Raga J, Knecht C, Szerman N, Martinez MI.

CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9. Review.

PMID:
23160939

Supplemental Content

Support Center